Skip to main content
NUFORMIX PLC logo

NUFORMIX PLC — Investor Relations & Filings

Ticker · NFX ISIN · GB00BYW79Y38 LEI · 2138003XG3H3I2J3BJ24 IL Professional, scientific and technical activities
Open in API
Filings indexed 279 across all filing types
Latest filing 2019-05-24 Major Shareholding Noti…
Country GB United Kingdom
Listing IL NFX

About NUFORMIX PLC

https://www.nuformix.com/

Nuformix PLC is a pharmaceutical development company focused on drug repurposing to address unmet medical needs, particularly in fibrosis and oncology. The company utilizes its expertise in cocrystal technology to unlock the therapeutic potential of approved drugs. This strategy involves creating new solid forms of existing medicines to improve their physical properties and performance, aiming to develop novel treatments with potentially accelerated development timelines.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document explicitly contains the header "RNS Number : 1041A" and references the "Financial Conduct Authority" (FCA). The content is structured as a "TR-1: Standard form for notification of major holdings," which details changes in voting rights percentages (e.g., crossing thresholds from 4.34% to 5.10%) by an individual shareholder (Mr Julian Higgins) in the issuer (Nuformix PLC). This type of filing, reporting changes in significant share ownership, directly corresponds to the Major Shareholding Notification category. Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2019-05-24 English
Loan Conversion
Regulatory Filings Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details a specific corporate action: the conversion of a loan note into ordinary shares and warrants. This action directly impacts the company's capital structure and share count. While it involves capital changes (CAP or SHA), the primary nature of this specific announcement—a notice of a transaction affecting shares/capital structure—fits best under Capital/Financing Update (CAP) or Share Issue/Capital Change (SHA). Since it is a direct notification of a financing settlement resulting in new shares, CAP is highly relevant, but SHA (Share Issue/Capital Change) is also a strong fit. Given the context of a loan conversion resulting in new shares being issued, SHA is the most precise fit for the resulting change in the share count. However, since this is a formal regulatory announcement distributed via RNS, and it details a specific transaction (loan conversion), it is a type of corporate action filing. Comparing CAP (Fundraising/Financing) and SHA (Share Issue/Capital Change), the issuance of shares upon conversion leans towards SHA. Given the RNS distribution and the specific nature of the transaction, it is a regulatory filing, but SHA is the most specific category for the event described.
2019-05-24 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings'. It explicitly details a change in share ownership (voting rights) by Spreadex Ltd in Nuformix PLC, crossing a reporting threshold. This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2019-05-22 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by Nuformix PLC. It details a change in share ownership by Spreadex Ltd, crossing a specific threshold. This is a classic 'Major Shareholding Notification' (MRQ) as defined by regulatory requirements for disclosing significant changes in voting rights.
2019-05-22 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains an 'RNS Number'. It details changes in voting rights percentages (crossing thresholds) held by a specific entity (SPREADEX LTD) in Nuformix PLC, referencing regulatory articles (like DTR5.1, DTR5.2.1). This structure is characteristic of a regulatory filing notifying a change in significant share ownership. This directly matches the definition for Major Shareholding Notification (MRQ). Although it is distributed via RNS, the core content is the notification itself, not just an announcement of a report.
2019-05-22 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document contains an 'RNS Number' and is explicitly stated to be provided by 'RNS, the news service of the London Stock Exchange,' which is approved by the Financial Conduct Authority (FCA). The content describes a 'Second Price Monitoring Extension' for a security, which is a specific type of market operational announcement related to trading halts or extensions. This type of general regulatory announcement that doesn't fit into specific financial reporting categories (like 10-K, ER, or DIV) is best classified under the general regulatory filing/announcement category.
2019-05-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.